JonesTrading Maintains a Buy on Prime Medicine (PRME)
Prime Medicine Inc. (NASDAQ:PRME) is one of the best biotech penny stocks to buy right now. On July 7, JonesTrading analyst Soumit Roy maintained a Buy rating on Prime Medicine Inc.
Prime Medicine Inc. (PRME)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 5,477,851 | $30,347,295 | +136% | 0.18% |
| 2. | Farallon Capital Thomas Steyer | 4,750,000 | $26,315,000 | +534% | 0.11% |
| 3. | Casdin Capital Eli Casdin | 3,167,175 | $17,546,150 | +103% | 1.46% |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,002,482 | $16,633,750 | 0.08% | |
| 5. | RA Capital Management Peter Kolchinsky | 3,000,000 | $16,620,000 | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.30 | 1,500,000 | $4,950,000.00 | 3,262,440 | 2025-08-01 | Filing | |
| $3.30 | 3,030,300 | $9,999,990.00 | 6,230,300 | 2025-08-01 | Filing | |
| $3.30 | 3,030,300 | $9,999,990.00 | 6,230,300 | 2025-08-01 | Filing | |
| $3.30 | 3,030,300 | $9,999,990.00 | 6,230,300 | 2025-08-01 | Filing | |
| $2.52 | 21,000 | $52,829.70 | 20,240,945 | 2025-06-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.97 | 19,003 | $284,495.81 | 0 | 2023-06-21 | Filing | |
| $15.06 | 37,405 | $563,248.23 | 0 | 2023-06-20 | Filing | |
| $15.02 | 6,532 | $98,109.33 | 0 | 2023-06-16 | Filing | |
| $14.92 | 66,659 | $994,325.64 | 0 | 2023-06-15 | Filing | |
| $14.87 | 28,960 | $430,684.43 | 0 | 2023-06-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,562,498 | $91,756,239 | 3.81% | |
| 2. | 5,650,859 | $31,305,758 | 0% | |
| 3. | 4,921,865 | $27,267,132 | 0% | |
| 4. | 3,629,924 | $20,109,779 | 0.01% | |
| 5. | 3,629,924 | $20,037,180 | 0.19% |
News See All
14 Best Biotech Penny Stocks to Buy Right Now
He acknowledged that biotech has been a “super tough sector” either way, as there are hundreds of publicly traded stocks that do not add up to anything in aggregate.
10 Hot Penny Stocks to Invest in Now
CNBC reported that consumer prices rose 2.7% year-over-year in June, suggesting that President Trump's tariffs are starting to be felt across the economy.
Prime Medicine Focuses on Genetic Liver Diseases, Partnered Programs After Positive CGD Data
Prime Medicine Inc. (NASDAQ:PRME) is one of the best hot stocks to buy according to Wall Street analysts.
11 Best Hot Stocks to Buy According to Wall Street Analysts
On July 1, Ralph Schlosstein, Evercore's chairman emeritus and BlackRock's co-founder, joined 'Closing Bell Overtime' on CNBC to talk about his outlook for markets heading into the second half of the ...
Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty
On Tuesday, Citi downgraded Prime Medicine Inc. (NASDAQ:PRME) from a Buy to a Neutral rating while also significantly reducing its price target from $10 to $1.50.
Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
12 Best Biotech Penny Stocks To Invest In Now
Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower borrowing costs: biotechnology stocks.
10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.